Nuclear Medicine and Biology
Volume 37, Issue 2 , Pages 143-148 , February 2010

A 1-methyl-4-piperidinyl cytectrene carboxylate labeled by the technetium 99m, a radiotracer for rat brain acetylcholinesterase activity

Received 16 July 2009 ,Revised 8 September 2009 ,Accepted 2 October 2009.

References 

  1. Whitehouse PJ, Price DL, Clark AW, Coyle JT, Delong MR. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol. 1981;10:122–126
  2. Munoz FJ, Aldunate R, Inestrosa NC. Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. NeuroReport. 1999;10:3621–3625
  3. Bowen DM, Dawison AN. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease. Br Med Bull. 1986;42:75–80
  4. Bierer LM, Haroutunian V, Gabriel S, Knoot PJ, Carlin LS, Purohit DP, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of cholinergic deficits. J. Neurochem. 1995;64:749–760
  5. Giacobini E. Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry. 2003;18:1–5
  6. Kuhl DE, Frey RA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 1999;52:691–699
  7. Kuhl D, Koeppe R, Minoshima S, Snyder S, Ficaro E, Foster N, et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 1999;52:691–699
  8. Tsakiris S, Angelogianni P, Stavridis JC. Effect of aging on the activities of acetylcholinesterase, Na+,K+-ATPase and Mg2+-ATPase in rat pituitary and hypothalamus. Z Naturforsch. 1998;53C:168–172
  9. Hammond P, Brimijoin J. Acetylcholinesterase in Huntingtons and Alzheimer's disease: simultaneous enzyme assay and immunoassay of multiple brain regions. J Neurochem. 1988;50:1111–1116
  10. Perry EK, Perry RH, Blessed G, Tomlinson E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropath Appl Neurobiol. 1978;4:273–277
  11. Kretzschmar M, Saïdi M, Bergmann R. A new 99mTc cytectrene derivative for in vivo imaging of the 5-HT1A receptor in the brain. Annu Rep FZR. 2002;363:53
  12. Saidi M, Kothari K, Pillai MRA, Hassan A, Sarma HD, Chaudhari PR, et al. Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies. J Label Compd Radiopharm. 2001;44:603–618
  13. Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T. Design and evaluation of radioactive acethylcholine analogues for mapping brain acetylcholinesterase (AchE) in vivo. Nucl Med Biol. 1994;21:801–808
  14. kilbourn MR, Nguyen TB, Snyder SE, Scherman PS. N-[11C]Methylpiperidine esters as acetylcholinesterase substrates: an in vivo structure–activity study. Nucl Med Biol. 1998;25:755–760
  15. Irie T, Fukushi K, Namaba H, Iyo M, Tamagami H, Nakatsuka S, et al. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease. Nucl Med. 1996;37:649–655
  16. Zang M, Tsuchiyama A, Haradahira T, Yoshida Y, Irie T, Suzuki K. Synthesis and preliminary evaluation of [18F]-FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo. Nucl Med Biol. 2002;29:463–468
  17. Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, et al. Measurement of acetylcholinesterase by positron emission tomography in the brain of healthy controls and patients with Alzheimer's disease. Lancet. 1997;349:1805–1809
  18. Namba H, Irie T, Fukushi K, Iyo M. In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog. Brain Res. 1994;667:278–282
  19. Wei JP, Burke GJ, Mansberger AR. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans. Ann Surg. 1994;219(5):568–573
  20. Wenzel M, Saïdi M. Ester der 99mTc-markierten Cytectren-Carbonsäure mit Alkoholen cyclischer Amine als Gehirn-affine Radiodiagnostika. J Label Compd Radiopharm. 1993;33:77–80
  21. Saidi M, Seifert S, Kretzschmar M, Bergmann R, Pietzsch H-J. Cyclopentadienyl tricarbonyl complexes of 99mTc for the in vivo imaging of the serotonin 5-HT1A receptor in the brain. J Organometallic Chem. 2004;689:4739–4744
  22. Saïdi M, Seifert S, Kretzschmar M, Bergmann R, Pietzsch HJ. 99mTc-Cytectrene Complexes — Chemical Structure and Biobehaviour: Part 1. Chemical Characterisation of Tc and Re Complexes, Annual Report 2003, Institute of Bioinorganic and radiopharmaceutical chemistry, FZR-394. In: 2004;p. 23
  23. Zhang M-R, Furutsuka K, Maeda J, Kikuchi T, Kida T, Okauchi T, et al. N-[18F]Fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): a PET tracer for imaging brain acetylcholinesterase in vivo. Bioorg Med Chem. 2003;11:2519–2527
  24. Shao X, Lisi JM, Butch ER, Kilbourn MR, Snyder SE. N-Methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity. Nucl Med Biol. 2003;30:293–302
  25. Alberto R, Egli A, Abram U, et al. Synthesis and reactivity of [NEt4]2[ReBr3(CO)3]: formation and structural characterization of the clusters [NEt4][Re3(_3-OH)(_-OH)3(CO)9] and [NEt4][Re2(_-OH)3(CO)6] by alkaline titration. J Chem Soc Dalton Trans. 1994;363:2815–2820
  26. Kikuchi T, Zhang M-R, Ikota N, Fukushi K, Okamura T, Suzuki K, et al. N-[18F]-Fluoroethylpiperidin-4ymethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity. J Med Chem. 2005;48:2577–2583
  27. Fersht A. In: Structure and mechanism in protein science. Cambridge University Press; 1999;p. 1–650

PII: S0969-8051(09)00240-6

doi: 10.1016/j.nucmedbio.2009.10.002

Nuclear Medicine and Biology
Volume 37, Issue 2 , Pages 143-148 , February 2010

Article Tools

* Image Usage & Resolution